Leo Creative

  • Home
  • About
  • Our Approach
  • Our Work
    • Branding
    • Healthcare
  • Contact

Launching a new treatment for Dupuytren’s contracture

Client: Janssen Australia

dupuytens

Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s contracture. Like most pharma branding, the creative was done overseas, so the task was to adapt global brand assets for the local Australia market.

A wide range of collateral was produced including mandatory items like product information and consumer medicine information, printed detail aid and e-detailer (Veeva iRep), physician and patient guides.

Filed Under: work

PAH Clinic: Speaker Tour Issue

Client: Janssen Australia When Janssen Australia sponsored a world-renowned Pulmonary Arterial Hypertension (PAH) expert to visit Australia, Leo Creative was commissioned to design a range of … MORE

Clinical Genomics capital raising

Client: Clinical Genomics Technologies Pty Ltd CGT was formed in 2006 to discover and deliver healthcare products that address the unmet needs of large healthcare markets. The company sells stool … MORE

Veeva iRep v Next Interact

After delivering our first project targeting Veeva’s iRep platform, here are some initial thoughts on creating content for these two widely used apps. In many ways comparing Next Interact with Veeva … MORE

A new brand story for Barker College

An audit of Barker College’s advertising and a review of quant and qual research led to a new brand story for Barker College. Following the successful delivery of a new enrolment prospectus, Barker … MORE

Copyright © 2026 Leo Creative Pty Ltd · Genesis Framework by StudioPress · Log in